Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 300 of 373 entries
View as:

Safety and Immunogenicity of Tdap Vaccine Compared to DTaP Vaccine in Children 4 to 6 Years of Age

Phase: N/A Priority: Normal
NCT ID: NCT00467519 Org: User:
Start: 04/30/07 End: 12/31/09 Due: 12/31/10

Safety, Tolerability, and Immunogenicity of ORI-A-ce001 for the Treatment of Acne Vulgaris

Phase: N/A Priority: Normal
NCT ID: NCT05131373 Org: User:
Start: 09/28/21 End: 11/27/23 Due: 11/27/24

Study to Evaluate the Effectiveness of a High-Dose Quadrivalent Influenza Vaccine (QIV-HD) Compared to a Standard-Dose Quadrivalent Influenza Vaccine (QIV-SD) in Adults 65 Years of Age and Older

Phase: N/A Priority: Normal
NCT ID: NCT04137887 Org: User:
Start: 11/04/19 End: 05/31/20 Due: 05/31/21

A Study on the Safety and Immunogenicity of Hexavalent Influenza mRNA Vaccine in Adult Participants 50 Years of Age and Older

Phase: N/A Priority: Normal
NCT ID: NCT06744205 Org: User:
Start: 01/06/25 End: 04/16/26 Due: 04/16/27

Efficacy and Safety of Dengue Vaccine in Healthy Children

Phase: N/A Priority: Normal
NCT ID: NCT00842530 Org: User:
Start: 02/28/09 End: 02/28/14 Due: 02/28/15

Safety of REPEVAX® Given One Month After REVAXIS®

Phase: N/A Priority: Normal
NCT ID: NCT00400309 Org: User:
Start: 06/30/06 End: 02/28/07 Due: 02/28/08

Study of an Investigational Pentavalent Meningococcal ABCYW Vaccine in Adults and Adolescents

Phase: N/A Priority: Normal
NCT ID: NCT06128733 Org: User:
Start: 10/31/23 End: 06/25/25 Due: 06/25/26

Dose-ranging Study of an Investigational Yellow Fever Candidate Vaccine in Adults

Phase: N/A Priority: Normal
NCT ID: NCT04142086 Org: User:
Start: 01/15/20 End: 06/24/21 Due: 06/24/22

Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Toddlers

Phase: N/A Priority: Normal
NCT ID: NCT03205358 Org: User:
Start: 03/31/15 End: 08/19/15 Due: 08/19/16

Safety of a Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine in Healthy Subjects in Vietnam

Phase: N/A Priority: Normal
NCT ID: NCT02640404 Org: User:
Start: 06/06/16 End: 12/05/16 Due: 12/05/17

Immune Lot Consistency, Immunogenicity, and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT02842853 Org: User:
Start: 07/15/16 End: 02/28/17 Due: 02/28/18

Immune Responses in Adults to Revaccination With ADACEL® 10 Years After a Previous Dose

Phase: N/A Priority: Normal
NCT ID: NCT00712959 Org: User:
Start: 06/30/08 End: 12/31/09 Due: 12/31/10

Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Patients ≥65 Years

Phase: N/A Priority: Normal
NCT ID: NCT03233217 Org: User:
Start: 09/15/17 End: 11/28/17 Due: 11/28/18

Observational Study to Evaluate the Safety of CYD Tetravalent Dengue Vaccine (CYD-TDV) in Pregnant Women and Their Offsprings Inadvertently Exposed During Pregnancy

Phase: N/A Priority: Normal
NCT ID: NCT04023708 Org: User:
Start: 03/11/22 End: 03/27/23 Due: 03/27/24

Post-marketing Surveillance Study for the Safety of a DTaP-IPV- HB-PRP~T Vaccine in Republic of Korea

Phase: N/A Priority: Normal
NCT ID: NCT06793826 Org: User:
Start: 01/17/25 End: 04/13/26 Due: 04/13/27

Immunogenicity of High-dose Inactivated, Split-virion Influenza Vaccine Versus Standard Fluzone Vaccine in the Elderly

Phase: N/A Priority: Normal
NCT ID: NCT00391053 Org: User:
Start: 10/31/06 End: 02/29/08 Due: 02/28/09

Study of SP306 Given Intramuscularly Compared to DT Given Subcutaneously in Japanese Adolescents 11 - 12 Years Old

Phase: N/A Priority: Normal
NCT ID: NCT02089347 Org: User:
Start: 03/31/14 End: 03/31/15 Due: 03/31/16

Safety of a Second Dose of Biken's Varicella Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT00830648 Org: User:
Start: 01/31/09 End: 12/31/09 Due: 12/31/10

Safety and Immunogenicity Study of a Diphtheria, Tetanus, Acellular Pertussis and Poliomyelitis Vaccine (REPEVAX) Followed by 2 Doses of a Diphtheria, Tetanus and Poliomyelitis Vaccine (REVAXIS) in Subjects of 40 Years of Age or Older

Phase: N/A Priority: Normal
NCT ID: NCT01287949 Org: User:
Start: 01/31/11 End: 05/31/12 Due: 05/31/13

Study of the Influenza Vaccine (Split Virion, Inactivated) Northern Hemisphere 2009-2010 Formulation (Intradermal Route)

Phase: N/A Priority: Normal
NCT ID: NCT00945438 Org: User:
Start: 05/31/09 End: 07/31/09 Due: 07/31/10

Study of Tetanus and Diphtheria Toxoids Adsorbed Combined With Component Pertussis Vaccine and Inactivated Poliomyelitis

Phase: N/A Priority: Normal
NCT ID: NCT02040636 Org: User:
Start: 01/31/99 End: 05/31/00 Due: 05/31/01

A Study of Japanese Encephalitis Chimeric Virus Vaccine Compared With SA14-14-2 Vaccine in Infants and Toddlers

Phase: N/A Priority: Normal
NCT ID: NCT01092507 Org: User:
Start: 03/31/10 End: 10/31/11 Due: 10/31/12

Study of a Candidate Clostridium Difficile Toxoid Vaccine in Healthy Adult Subjects Aged 40 to 75 Years in Japan

Phase: N/A Priority: Normal
NCT ID: NCT01896830 Org: User:
Start: 07/31/13 End: 06/30/14 Due: 06/30/15

Study of Menactra® in Healthy Subjects at 9 Months and Concomitantly With Pentacel® at 15 to 18 Months of Age

Phase: N/A Priority: Normal
NCT ID: NCT01659996 Org: User:
Start: 07/31/12 End: 09/30/15 Due: 09/30/16

Safety Surveillance of VaxigripTetra® and Efluelda® Influenza Vaccines in Europe During the Influenza Season 2022/23

Phase: N/A Priority: Normal
NCT ID: NCT05568979 Org: User:
Start: 10/06/22 End: 11/29/22 Due: 11/29/23